Skip to main content
Premium Trial:

Request an Annual Quote

GenMark, ALL Ink Definitive Agreement for IVD Platform Development

NEW YORK (GenomeWeb News) – GenMark Diagnostics and Advanced Liquid Logic today said they have executed definitive agreements to co-develop an all-digital, fully integrated in vitro diagnostic platform combining ALL's electrowetting technology and GenMark's electrochemical detection.

Today's agreement follows a preliminary deal announced by the firms earlier this year to develop the diagnostics platform. As part of the deal, Carlsbad, Calif.-based GenMark will pay ALL up to $3 million in license fees, contingent milestone payments, and an equity investment.

ALL, based in Durham, NC, develops microfluidics products for newborn screening and genomic sample preparation.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.